علاج سرطان الخلايا الكبدية المنفرد في المرحلة المبكرة (≤5 سم) عند عدم إجراء الجراحة

References

DOI: 10.1097/HEP.0000000000000466

1. Patients with solitary tumors ≤5 cm should be treated with curative intent using local ablative therapies if they are ineligible for or decline surgical therapy (Level 1, Strong Recommendation).
2. Thermal ablation (radiofrequency or microwave ablation) should be considered the treatment of choice for patients with early-stage HCC ≤ 3 cm who are ineligible for or decline surgery (Level 1, Strong Recommendation).
3. Targeted radioembolization (radiation segmentectomy) or EBRT may be used as alternative therapies to thermal ablation for patients with BCLC stage A HCC who are not candidates for surgical resection, including those with tumors >3 cm in size (Level 3, Strong Recommendation).